CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 164 filers reported holding CARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $195 | -99.0% | 116 | -98.4% | 0.00% | – |
| Q2 2023 | $20,410 | -71.5% | 7,212 | -50.6% | 0.00% | – |
| Q1 2023 | $71,664 | -98.7% | 14,596 | -96.8% | 0.00% | -100.0% |
| Q1 2022 | $5,578,000 | +27.8% | 459,100 | +28.1% | 0.02% | +29.4% |
| Q4 2021 | $4,364,000 | +225.7% | 358,300 | +330.6% | 0.02% | +142.9% |
| Q4 2019 | $1,340,000 | -51.8% | 83,200 | -45.3% | 0.01% | -58.8% |
| Q3 2019 | $2,780,000 | +55.1% | 152,096 | +66.5% | 0.02% | +112.5% |
| Q1 2019 | $1,792,000 | +132.7% | 91,324 | +82.6% | 0.01% | +100.0% |
| Q2 2017 | $770,000 | -16.3% | 50,000 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $920,000 | -89.7% | 50,000 | -90.6% | 0.01% | -93.2% |
| Q4 2015 | $8,939,000 | +2425.1% | 530,200 | +2037.9% | 0.07% | +2366.7% |
| Q3 2015 | $354,000 | -41.6% | 24,800 | -50.3% | 0.00% | -25.0% |
| Q2 2015 | $606,000 | – | 49,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |